PlainRecalls
FDA Drug Moderate Class II Terminated

Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.

Reported: December 18, 2019 Initiated: December 2, 2019 #D-0576-2020

Product Description

Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.

Reason for Recall

Presence of Foreign Substance: Presence of a foreign object in a single tablet.

Details

Units Affected
1,824 bottles
Distribution
Nationwide in the USA.
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 1,824 bottles.
Why was this product recalled?
Presence of Foreign Substance: Presence of a foreign object in a single tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 18, 2019. Severity: Moderate. Recall number: D-0576-2020.